Camtek (CAMT) Registers a Bigger Fall Than the Market: Important Facts to Note

Camtek closed at $126.67, down 1.64% on the day, underperforming the S&P 500’s 0.31% decline; the article also notes the shares had fallen 17.05% before the session, versus a 3.14% sector decline and a 0.87% S&P 500 gain. Ahead of its November 4, 2026 earnings release, consensus forecasts are $0.98 EPS and $160.37 million revenue, up 19.51% and 27.28% year over year; full-year estimates are $3.62 EPS and $595.32 million revenue. Consensus EPS estimates rose 0.56% over the past month, and Camtek has a Zacks Rank of #2 (Buy); its forward P/E is 35.53 versus 37.42 for the industry, while its PEG of 2.33 exceeds the industry’s 1.64.

Analysis

The key signal is the divergence between a sharp recent drawdown and slightly higher near-term EPS estimates: price action is discounting something estimates have not yet captured, or simply unwinding a crowded/high-duration valuation. The article provides no order, bookings, customer, or guidance data to distinguish those explanations. For a semiconductor equipment name, the November 4 release should be judged on forward demand indicators and conversion of revenue growth into margins—not just an EPS beat against a consensus that may lag changing expectations.

The apparent forward-P/E discount to a broad industry set is not a clear valuation floor: the reported PEG premium suggests the relative case depends on growth durability, and the comparison may not match Camtek’s closest inspection-equipment peers. A further estimate cut or softer forward commentary could therefore compress the multiple even if the quarter meets current forecasts. Conversely, stable bookings and outlook could force shorts or sidelined investors to reassess the selloff. Over 6–18 months, any change in advanced-packaging investment intensity could flow through to inspection-tool demand; competitors such as Onto Innovation and KLA are relevant read-throughs, but the article supplies no evidence of share gains or losses. Treat the Zacks rank and its historical-return claim as promotional inputs, not independent validation.

Key Decisions for Investors

• Avoid initiating a directional CAMT position immediately ahead of November 4 solely on the estimate uptick or the recent underperformance; event risk is elevated and the article lacks the operating data needed to underwrite the move.
• For existing exposure, keep risk bounded through the release. Reassess against forward bookings/orders, revenue outlook, and gross-margin commentary; an EPS beat without stronger forward demand would not, by itself, falsify the de-rating thesis.
• Consider a post-earnings long only if management’s forward demand indicators hold up and estimates stabilize or rise; the thesis is falsified by weaker guidance, declining orders, or renewed downward estimate revisions. Do not add simply because the shares have fallen.
• Watch whether the selloff broadens to Onto Innovation and KLA or remains CAMT-specific. Relative weakness alongside peer strength would raise the probability of company-specific expectation resets; sector-wide weakness would point more toward semiconductor-capex risk.